Rayonier Advanced Materials (RYAM) 17th Annual Southwest IDEAS Conference summary
Event summary combining transcript, slides, and related documents.
17th Annual Southwest IDEAS Conference summary
3 Feb, 2026Business overview and segment performance
Operates four facilities across the US, France, and Canada, producing natural cellulose fibers used globally in everyday products.
Five segments: cellulose specialties (core), cellulose commodities, biomaterials (future growth), paperboard, and high-yield pulp.
Specialty products are used in food, pharmaceuticals, cigarette filters, plastics, and automotive filtration.
Commodities include fluff for hygiene products and viscose for textiles; assets can shift between specialties and commodities based on demand.
Paperboard and high-yield pulp, mainly in Canada, face market challenges but have new product launches like freezer board.
Financial performance and outlook
2023 guidance revised from $215–$235 million EBITDA to $135–$140 million due to tariffs, currency, and operational issues, mainly in France.
Tariff headwinds have shifted to tailwinds, with zero tariffs on most exports and new tariffs supporting US manufacturing.
Industry harmed by imports from Brazil and Norway; additional tariffs pending.
Targeting a baseline EBITDA of $195 million, aiming to double to $315 million by end of 2027 through price, volume, cost reductions, and biomaterials investments.
Growth strategies and market dynamics
Price increases and volume growth in cellulose specialties expected, with industry utilization at 90% and no new capacity until at least 2029.
Market analysts expect 4–6% annual price growth; management is more bullish for 2026.
Plans to convert commodity production to specialty grades for margin enhancement.
Biomaterials segment to leverage existing assets for new products like bioethanol, green energy, and prebiotics, with $80 million EBITDA potential from $60 million capital over 2–3 years.
Exploring sustainable aviation fuel and pilot-scale bioethanol projects with external partners and grants.
Latest events from Rayonier Advanced Materials
- Board refresh, CEO change, and governance reforms highlight a focus on accountability and performance.RYAM
Proxy filing20 Mar 2026 - 2026 targets positive cash flow, EBITDA growth, and new product launches amid disciplined execution.RYAM
Gabelli Funds Annual Specialty Chemicals Symposium20 Mar 2026 - 2025 results showed lower revenue and EBITDA, with 2026 targeting free cash flow recovery.RYAM
Q4 20254 Mar 2026 - Transformation to specialty cellulose, innovation, and sustainability drive growth and profitability.RYAM
Fireside Chat3 Feb 2026 - Shifting to specialty cellulose and biomaterials, with debt reduction and margin expansion in focus.RYAM
Small-Cap Growth Virtual Investor Conference3 Feb 2026 - Q2 net sales and earnings surged, with 2024 guidance raised and cash flow outlook improved.RYAM
Q2 20242 Feb 2026 - Shifting to specialty cellulose and biomaterials, with asset sales and debt reduction underway.RYAM
Stifel 2024 Cross Sector Insight Conference1 Feb 2026 - Q3 net sales and Adjusted EBITDA surged, 2024 guidance held, and $700M refinancing secured.RYAM
Q3 202416 Jan 2026 - Focus on specialty cellulose, biomaterials, and debt reduction drives margin and cash flow growth.RYAM
Gabelli Funds' 16th Annual Specialty Chemicals Symposium26 Dec 2025